WithdrawnPhase 3

Transversus Abdominis Plane (TAP) Block for Post Caesarian Pain

Stopped: We never collected data or started to recruit participants

United States0Started 2013-02

Plain-language summary

Adding TAP block with Bupivacaine may decrease the use of PCA bolus use after caesarean section for pain relief.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Healthy pregnant (ASA II) patients presenting for planned Cesarean delivery at New York Methodist Hospital under combined spinal epidural anesthesia Exclusion Criteria: * They are unable or are unwilling to take part in the study * They have a history of allergy to any of the medications to be used in the study * They have a history of drug abuse or chronic pain or opioid use * They weigh less than 60kg * They have a multiple gestation, placental disease, preeclampsia other disease of pregnancy * They have a contraindication to neuraxial anesthesia (i.e., bleeding problems, bacteremia, etc.) * They are unable to understand instructions or questions related to the study * ASA III or IV

What they're measuring

Transversus Abdominis Plane (TAP) Block for Post Caesarean Pain

Timeframe: The first post operative 24 hours

Trial details

NCT IDNCT01986049

SponsorNew York Presbyterian Brooklyn Methodist Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-08

View on ClinicalTrials.gov More Obstetrical Complications From Sedation During Parturition trials